Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade B 5.22 -1.32% -0.07
AUPH closed down 1.32 percent on Friday, February 16, 2018, on 29 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
26 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical AUPH trend table...

Date Alert Name Type % Chg
Feb 16 Narrow Range Bar Range Contraction 0.00%
Feb 16 NR7 Range Contraction 0.00%
Feb 16 NR7-2 Range Contraction 0.00%
Feb 16 Wide Bands Range Expansion 0.00%
Feb 15 NR7 Range Contraction -1.32%
Feb 15 Inside Day Range Contraction -1.32%
Feb 15 Wide Bands Range Expansion -1.32%
Feb 14 Wide Bands Range Expansion -1.88%
Feb 14 Up 3 Days in a Row Strength -1.88%
Feb 14 Up 4 Days in a Row Strength -1.88%

Older signals for AUPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Is AUPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.54
52 Week Low 3.23
Average Volume 1,006,587
200-Day Moving Average 5.9636
50-Day Moving Average 5.1361
20-Day Moving Average 5.3568
10-Day Moving Average 5.163
Average True Range 0.2612
ADX 18.81
+DI 18.26
-DI 19.35
Chandelier Exit (Long, 3 ATRs ) 5.3214
Chandelier Exit (Short, 3 ATRs ) 5.5436
Upper Bollinger Band 5.9647
Lower Bollinger Band 4.7489
Percent B (%b) 0.39
BandWidth 22.696386
MACD Line -0.0168
MACD Signal Line -0.0074
MACD Histogram -0.0095
Fundamentals Value
Market Cap 435.79 Million
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -4.02
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.42
Resistance 3 (R3) 5.43 5.38 5.38
Resistance 2 (R2) 5.38 5.33 5.37 5.37
Resistance 1 (R1) 5.30 5.30 5.28 5.29 5.36
Pivot Point 5.25 5.25 5.24 5.24 5.25
Support 1 (S1) 5.17 5.20 5.15 5.16 5.08
Support 2 (S2) 5.12 5.17 5.11 5.07
Support 3 (S3) 5.04 5.12 5.06
Support 4 (S4) 5.03